NEU 0.46% $19.30 neuren pharmaceuticals limited

I think you completely missed the point. DAYBUE is not the key...

  1. 1,177 Posts.
    lightbulb Created with Sketch. 304
    I think you completely missed the point. DAYBUE is not the key value driver for NEU SP at this moment. This is not my words but from all the analysts covering NEU. While PMS sample size was small, the result was overwhelmingly positive and was not by chance.

    The significance of the Pit Hopkins and Angelman results is that it adds further weight to the investment theory that NNZ2561 has the potential to treat many other neurological illnesses
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.30
Change
-0.090(0.46%)
Mkt cap ! $2.466B
Open High Low Value Volume
$19.55 $19.65 $18.88 $10.53M 549.5K

Buyers (Bids)

No. Vol. Price($)
4 4552 $19.15
 

Sellers (Offers)

Price($) Vol. No.
$19.30 674 2
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.